Table 4.

Clinical pharmacist's interventions in managing identified drug–drug interactions (N = 273)

Clinical pharmacist's intervention	n (%)
At prescriber level
Prescriber informed only	12308 (2.9)
Prescriber asked for information	23 (8.4)
Intervention proposed to prescriber	61 (22.4)
Intervention discussed with prescriber	181 (66.3)
At drug level
Drug changed	23 (8.4)
Dosage changed	53 (19.4)
Formulation changed	11 (4)
Instructions for use changed	27 (10)
Drug stopped	47 (17.2)
Other intervention (outcome monitored)
Blood glucose monitored more frequently	33 (12.1)
Blood pressure monitored more closely	29 (10.6)
Serum electrolytes monitored more frequently	23 (8.4)
Heart rate monitored more closely	19 (7)
Serum creatinine monitored more frequently	8 (2.9)
Acceptance of the intervention by prescriber
Intervention accepted and fully implemented	251 (92)
Intervention accepted, partially implemented	17 (6.2)
Intervention accepted but not implemented	5 (1.8)